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Summary
Background.  —  Much  attention  is  being  paid  to  the  education  of  and  provision  of  medical  infor-
mation to  patients,  to  optimize  their  understanding  and  acceptance  of  their  disease.
Aims. —  To  ascertain  the  impact  of  educating  recent  recipients  of  an  implantable  cardioverter
deﬁbrillator  (ICD)  on  their  perception  and  acceptance  of  a  home  monitoring  (HM)  system.
Methods.  —  Questionnaire  1,  completed  one  month  after  ICD  implantation,  was  designed  to
assess: the  quality  of  patient  preparation  for  HM;  patient  comprehension  of  HM;  and  patient
anxiety experienced  during  its  installation.  The  comprehension  questions  were  assigned  a  score
of —2  for  an  incorrect  answer,  +1  for  a  correct  answer  and  0  for  neither  (total  score  ranging  from
—40 to  +20).  Questionnaire  2,  completed  six  months  after  ICD  implantation,  assessed  patient
acceptance  of  and  anxiety  about  HM.
Results.  —  The  registry  included  571  patients  (mean  age  63.9  ±  12.8  years;  83%  men;  76%  of
ICDs implanted  for  primary  prevention)  followed  by  HM  for  6.2  ±  1.2  months.  Questionnaire  1
was completed  by  430  (75.3%)  patients  and  questionnaire  2  by  398  (69.7%)  patients.  Younger
patients  had  a  better  comprehension  of  HM  than  older  patients.  High-quality  training  conditions
improved  the  comprehension  score,  and  a  positive  association  was  observed  between  anxiety
and acceptance  levels  and  the  comprehension  score.  The  80  ±  20%  mean  data  transmission  rate
(days of  transmission/days  of  follow-up  ratio)  was  unrelated  to  the  comprehension  scores.
Conclusion.  —  A  clear  understanding  was  associated  with  a  higher  acceptance  of  HM,  although
it was  unrelated  to  the  data  transmission  rate.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Un  grand  intérêt  est  porté  à  l’éducation  et  l’information  des  patients  et  de  leur
entourage,  aﬁn  d’améliorer  leurs  connaissances  de  la  maladie.
Objectifs.  —  Déterminer  l’importance  de  l’éducation  des  porteurs  de  déﬁbrillateurs  automa-
tiques implantables  (DAI)  concernant  leur  perception  et  acceptation  de  la  télécardiologie.
Méthodes.  —  Le  premier  questionnaire  (Q-1)  complété  1  mois  après  l’implantation  des  DAI,
fut conc¸u  pour  examiner  (1)  la  qualité  de  la  formation  des  patients  en  télécardiologie,  (2)  leur
compréhension  du  système,  et  (3)  l’anxiété  qu’ils  ressentirent  lors  de  l’installation.  Un  score  de
compréhension  s’étendant  de  —40  à  +20  fut  calculé  en  attribuant  —2  aux  réponses  incorrectes,
+1 aux  réponses  correctes  et  0  aux  réponses  manquantes.  Le  questionnaire  2  (Q-2),  complété
6 mois  après  l’implantation  des  DAI,  fut  conc¸u pour  évaluer  l’acceptation  et  l’anxiété  de  la
télécardiologie.
Résultats. —  Le  registre  a  inclus  571  patients  (âge  moyen  =  63,9  ±  12,8  ans,  83  %  d’hommes,  76  %
de prévention  primaire)  suivis  par  télécardiologie  pendant  6,2  ±  1,2  mois.  Q-1  fut  complété  par
430 (75,3  %)  et  Q-2  par  398  (69,7  %)  patients.  Les  plus  jeunes  avaient  une  meilleure  compré-
hension de  la  télécardiologie  que  les  plus  âgés.  Une  formation  dans  de  bonnes  conditions  a
amélioré le  score  de  compréhension  et  une  association  signiﬁcative  fut  identiﬁée  entre  le
niveau d’anxiété  et  d’acceptation,  et  le  niveau  de  compréhension.  Le  taux  de  transmission
moyen (nombre  de  jours  de  transmission/nombre  de  jours  de  suivi)  fut  80  ±  20  %  et  n’était  pas
lié à  la  compréhension.
Conclusion.  — Indépendamment  du  taux  de  transmission,  la  compréhension  de  la  télécardiologie
était associée  avec  son  acceptation.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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aIntroduction
The  remote  monitoring  of  implantable  cardiac  devices  is
safe  and  effective,  and  is  fast  becoming  the  standard
of  care  for  the  follow-up  of  pacemaker  and  implantable
cardioverter  deﬁbrillator  (ICD)  recipients  [1—5].  However,
there  are  few  published  reports  pertaining  to  patient  accep-
tance  of  these  systems  and  the  fear  that  they  might  cause
s
t
d6—9]. On  the  other  hand,  caregivers  and  investigators  have
ecognised  the  need  to  include  patient  perceptions  and
references  when  making  health  management  decisions.
onsequently,  growing  attention  is  being  paid  to  educating
nd  informing  patients,  with  a  view  to  promote  their  under-
tanding  of  their  disease  —  a  perspective  that  might  help  in
he  development  of  innovative  strategies  and  improve  the
elivery  of  specialized  health  care.
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and  the  eagerness  to  pursue  HM-based  follow-ups  after  the10  
Biotronik  Home-Monitoring® (HM;  a  system  developed  by
iotronik  SE  and  Co.  KG,  Berlin,  Germany)  provides  diag-
ostic  information,  periodic  trends  and  event-triggered  ICD
ata,  which  are  transmitted  to  a  secure  website  accessible
emotely  by  physicians.  To  reach  this  objective,  we  hypoth-
sized:  that  patients  must  understand  the  main  goals  and
perating  principles  of  the  technology  to  ensure  regular
ata  transmission;  and  that  focusing  on  patient  anxiety  and
omprehension  would  improve  their  training  and  success-
ul  participation  in  the  use  of  this  technology.  Therefore,
he  EDUCAT  observational  study  was  designed  to  examine
hether  a  correlation  exists  between  understanding  and
linical  acceptance  of  HM.
ethods
tudy objective
he  aim  of  this  study  was  to  assess  patients’  understand-
ng  of  an  ICD  and  their  acceptance  of  and  anxiety  about
M,  using  two  dedicated  questionnaires  (Q-1  and  Q-2).  The
cores  were  compared  to  determine  whether  a  relationship
xists  between  comprehension  and  overall  acceptance  of
M.
atient selection
atients  were  included  in  the  EDUCAT  registry  after  they
ad  undergone  a  ﬁrst  implantation  of  a  LUMAX  VR-T  ICD,
 DR-T  ICD  or  an  HF-T  ICD  (Biotronik),  with  HM  activated.
atients  in  New  York  Heart  Association  functional  class  IV  at
he  time  of  ICD  implantation  were  excluded  from  the  reg-
stry.  All  patients  gave  written  informed  consent  to  their
articipation  in  the  EDUCAT  study,  which  complied  with  the
eclaration  of  Helsinki.
onitoring system and training
M  transmits  data  daily  and  automatically  to  the  Biotronik
ervice  Centre.  The  encrypted  messages  are  transmitted
y  the  Biotronik  CardioMessenger® device  (CM;  Biotronik  SE
nd  Co.  KG,  Berlin,  Germany)  over  a  wireless  global  system
or  mobile  communications  network.  The  data  are  analysed
utomatically  and  posted  on  a  secure  website  accessible  to
he  caregivers.  Notiﬁcations  are  issued  by  the  service  centre
o  the  designated  recipient  in  case  of  clinical  or  technical
ssues.  Patients  signed  an  informed  consent  form  for  the  HM
ystem  and  were  trained  on  its  use  during  the  index  hos-
italization,  after  the  ICD  implantation.  Depending  on  the
entre’s  usual  practice,  the  training  was  the  responsibility
f  a  physician  or  a  nurse,  or  an  ICD  manufacturer’s  repre-
entative.  All  pertinent  information  regarding  the  use  of  HM
nd  the  CM  was  delivered  orally  as  well  as  in  a  printed  man-
al,  which  included  a  toll-free  telephone  number  available
o  the  patients  10  hours/day,  5  days/week,  should  they  be
n  need  of  more  information  or  technical  support.tudy protocol
his  observational  study,  in  which  27  public  (387  patients)
nd  19  private  (184  patients)  French  medical  centres
e
+
u
tG.  Laurent  et  al.
articipated  (see  Appendix),  was  sponsored  by  Biotronik,
hich  contributed  to  the  study  design  and  data  monitor-
ng.  The  patients  were  enrolled  in  the  study  at  the  time  of
heir  discharge  from  the  hospital,  after  implantation  of  the
CD.  Patients  were  registered  on  a  secure  website  and  fol-
owed  remotely  for  approximately  six  months.  Follow-ups
ere  left  to  the  physician’s  discretion,  although  they  had
o  comply  with  the  Expert  Consensus  on  the  Monitoring  of
ardiovascular  Implantable  Electronic  Devices  (i.e.  face-to-
ace  visits  within  72  hours  and  between  two  and  12  weeks
fter  device  implantation,  and  every  3—6  months  thereafter,
ither  face-to-face  or  remotely)  [10].
uestionnaires
-1,  handed  to  the  patient  at  the  time  of  study  enrolment,
as  to  be  completed  anonymously  one  month  after  ICD
mplantation  and  returned  by  mail  in  a  prepaid  envelope,
o  evaluate  the  quality  of  the  training  delivered  at  individ-
al  implantation  centres.  The  ﬁrst  section  of  Q-1  examined
he  quality  of  the  training  from  the  patient’s  perspective,
ncluding  the  training  conditions  and  level  of  interest  in
he  content  (Table  1).  In  20  multiple-choice  questions,  the
ext  section  of  Q-1  tested  the  patient’s  skills  in  the  use  of
M  (Fig.  1).  The  last  section  of  Q-1  evaluated  whether  the
atient  found  home  installation  of  the  CM  simple  or  compli-
ated.
Q-2,  completed  six  months  after  ICD  implantation  and
eturned  anonymously  by  mail  in  a prepaid  envelope,  mea-
ured  the  anxiety  generated  by  the  technology  and  the
atient’s  acceptance  of  HM  (Fig.  2).
core calculations
he  second  part  of  Q-1  consisted  of  20  true  or  false  technical
nd  medical  queries.  The  score  ranged  from  —40  to  +20,  with
2  assigned  to  an  incorrect  answer,  +1  to  a  correct  answer
nd  0  to  an  unanswered  question  (Fig.  1).
The  Q-2  acceptance  score  was  based  on  questions  per-
aining  to  system  ergonomics,  device  usefulness,  technical
upport  service,  medical  care  delivered  and  overall  system
alue.  For  each  question,  the  score  was  —1  for  a  non-
pproval  answer,  +1  for  an  approval  answer  and  0 for  an
nanswered  question.  The  acceptance  score  ranged  from  —5
o  +5.
The  Q-2  anxiety  score  was  calculated  from  questions  per-
aining  to:  how  the  CM  is  perceived  (score  from  —4  for
avourable  perception  to  +4  for  unfavourable  perception);
he  frequency  with  which  the  patient  veriﬁed  the  proper
unctioning  of  the  CM  (score  from  —2  for  high  frequency
o  +2  for  low  frequency);  trust  in  HM  (score  of  —1  for  an
nxiety  answer  and  +1  for  a  non-anxiety  answer);  the  level
f  stress  during  home  installation  of  the  CM  (score  of  —1
or  an  anxiety  answer  and  +1  for  a  non-anxiety  answer);
he  level  of  anxiety  triggered  by  a  phone  call  (score  of  —1
or  an  anxiety  answer  and  +1  for  a  non-anxiety  answer);nd  of  the  study  (score  of  —1  for  an  anxiety  answer  and
1  for  a  non-anxiety  answer).  With  a  score  of  0  for  an
nanswered  question,  the  anxiety  score  ranged  from  —10
o  +10.
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Table  1  Univariate  and  multivariable  linear  regression  analyses  of  the  home  monitoring  comprehension  score.
Analysis
Univariate  P Multivariable  P
Clinical  characteristics
Age  —0.11  (—0.16;  —0.07)  <  0.001a —0.08  (—0.14;  —0.01)  0.023
Training  conditions
Reading  of  consent  form  (yes/no)  —1.43  (—2.59;  —0.28)  0.040a —2.85  (—4.84;  —0.86)  0.005
CM  delivery  (within  hours  of
implantation  versus  during
hospitalisation)
—0.12  (—0.82;  —0.59)  0.863
Qualiﬁcation  of  the  trainer  (medical
staff  versus  manufacturer’s
representative)
1.27  (0.20;  2.34)  0.026a
Presence  of  a  close  relative  (yes/no)  —0.24  (—1.46;  0.98)  0.914
Quality  of  the  presentation  (brief
versus  detailed/with  versus  without
device  handling)
0.19  (—0.21;  0.58)  0.023a
>  versus  <  5-minute  training  session —0.04  (—1.13;  1.05) 0.893
All  patient’s  questions  answered  by
trainer  (yes/no)
1.47  (0.40;  2.53) 0.012a
Clarity  of  presentation  (did/did  not
understand  the  value  of  HM)
—1.41  (—1.96;  —0.87)  <  0.001a —1.42  (—2.50;  —0.33)  0.011
Familiarity  with  the  user  manual
(yes/no)
—2.82  (—4.29;  —1.36)  <  0.001a
Awareness  of  access  to  a  toll-free
telephone  number  (yes/no)
—4.53 (—6.16;  —2.90)  <  0.001a —3.90  (—6.14;  —1.65)  0.001
Presentation  was  interesting
(yes/no)
4.08  (—0.34;  8.49)  0.089a
Home  installation  of  the  CM
Simple  (yes/no)  —3.48  (—6.59;  —0.36)  0.108a
Stressful  (yes/no)  2.86  (0.72;  4.99)  0.009a 4.62  (1.73;  7.50)  0.002
Data are  (95% conﬁdence interval). CM: CardioMessenger®; HM: home monitoring.
a Values entered into the multivariable model.
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Clinical  characteristics  are  expressed  as  mean  ±  standard
deviations  for  continuous  variables  and  as  counts  and  per-
centages  for  categorical  variables.  The  distributions  of
categorical  variables  were  examined  by  the  chi-square  test
or  Fisher’s  exact  test,  as  appropriate.  Continuous  variables
were  compared  using  Student’s  t  test  or  the  Mann—Whitney
U  test,  as  appropriate.  The  normal  distribution  of  variables
was  tested  using  the  Kolmogorov—Smirnov  and  Shapiro—Wilk
tests.  The  data  transmission  rate  was  calculated  by  divid-
ing  the  number  of  transmission  days  by  the  number  of
days  between  enrolment  and  the  end  of  the  study.  The
relationships  between  patient  comprehension  (dependent
variable)  and  training  conditions  (independent  variable),
and  between  patient  satisfaction  with  HM  (dependent
variable)  and  patient  comprehension  and  other  potential
independent  variables  were  assessed  using  a  multivari-
able  linear  regression  model.  The  relationship  between
patients  who  received  ≥  one  shock  (dependent  variable)  and
the  approval  score  and  other  potential  independent  varia-
bles  was  then  examined  using  a  logistic  regression  model
B
(
salidated  by  the  test  of  Hosmer  and  Lemeshow.  A  step-
ise  backward  elimination  was  used  for  the  three  models.
o  statistically  signiﬁcant  interaction  was  detected  among
he  variables  entered  in  the  models.  Variables  emerging  at
 P  <  0.2  level  of  signiﬁcance  by  univariate  analysis  were
ntered  into  the  multivariable  model.  A  P  value  <  0.05  was
onsidered  statistically  signiﬁcant.  A  receiver  operating
haracteristic  curve  was  also  plotted  and  the  area  under
he  curve  was  calculated,  with  its  95%  conﬁdence  interval.
The  questionnaires  were  validated  by  Cronbach’s  alpha
oefﬁcient.  The  analyses  were  performed  using  SPSS  soft-
are  for  windows,  version  19.0  (IBM  Corporation,  Armonk,
Y,  USA)  or  R  software,  version  2.14.1.
esults
ample populationetween  February  2009  and  February  2011,  571  patients
mean  age  63.9  ±  12.8  years;  83%  men)  were  included  in  the
tudy;  their  baseline  characteristics  are  shown  in  Table  2.
512  G.  Laurent  et  al.
F d sc
C le ca
T
n
(
t
s
(
t
t
Q
P
O
w
a
t
C
B
c
(
T
W
a
p
a
t
b
w
m
b
H
H
p
sigure 1. Questionnaire 1. List of queries, correct answers an
ardioMessenger®; F: false; HM: Home-Monitoring®; ICD: implantab
he  mean  duration  of  follow-up  was  6.2  ±  1.2  months.  The
umbers  of  completed  and  returned  Q-1s  and  Q-2s  were  430
75.3%)  and  398  (69.7%),  respectively.  The  clinical  charac-
eristics  of  the  patients  who  completed  Q-1  and  Q-2  were
imilar.  During  the  study,  33  patients  (5.8%)  died  and  11
1.9%)  exited,  including  six  whose  ICDs  were  explanted,
hree  who  were  lost  to  follow-up  and  two  who  withdrew
heir  consent.
uestionnaire 1
atient  comprehension
n  a  scale  from  —40  to  +20,  the  mean  comprehension  score
as  10.9  ±  5.6,  including  a  mean  medical  score  of  4.6  ±  3.7
nd  a  mean  technical  score  of  6.4  ±  3.0  on  a  scale  from  —20
o  +10  (Fig.  1).linical  characteristics
y  univariate  analysis,  old  age  was  the  only  clinical
haracteristic  associated  with  a  low  comprehension  score
P  <  0.001).
i
c
aores achieved by the EDUCAT patient sample. A: answers; CM:
rdioverter deﬁbrillator; SD: standard deviation; T: true.
raining  conditions
e  found  associations  between  the  comprehension  score
nd  several  training  characteristics  (Table  1).  For  exam-
le,  the  qualiﬁcations  and  attention  of  the  trainer  were
ssociated  with  a  high  score,  especially  when  a  clear,
hought-provoking  and  detailed  presentation  was  delivered
y  a  representative  of  the  device  manufacturer.  The  score
as  also  inﬂuenced  by  reading  the  consent  form  and  user
anual,  and  by  the  awareness  of  technical  support  accessi-
le  via  a  toll-free  telephone  number,  as  needed.
ome  installation  of  the  CardioMessenger® device
ome  installation  of  the  CM  was  stress  free  in  366  of  393
atients  (93%),  which  positively  inﬂuenced  the  comprehen-
ion  score.By  multivariable  analysis,  young  age,  reading  the
nformed  consent  form,  understanding  the  HM  operation  and
ontributions,  personal  handling  of  the  CM,  awareness  of
ccess  to  assistance  via  a  toll-free  telephone  number  and
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score at a P < 0.05 level. CM: CardioMessenger®; ICD: implantable c
stress-free  home  installation  of  the  CM  were  factors  associ-
ated  with  a  high  comprehension  score  (Table  1).
Questionnaire 2
Anxiety  about  Home-Monitoring®
On  a  scale  from  —10  to  +10,  the  mean  anxiety  score  was
5.0  ±  2.3.  Patients  generally  described  the  CM  as  unobtru-
sive,  simple,  small  and  reassuring  (Fig.  2A).  Patients  who
deﬁned  the  CM  as  small  or  simple  had  higher  comprehen-
sion  scores  than  those  who  described  the  CM  as  bulky  or
complicated  (P  =  0.05  and  P  =  0.002,  respectively).  Patients
who  rarely  veriﬁed  that  the  CM  was  functioning  properly  had
higher  skill  scores  than  patients  who  veriﬁed  this  regularly
(P  =  0.002).  Over  90%  of  patients  did  not  fear  that  a  phone
call  was  heralding  an  adverse  event  (Fig.  2A)  and  they  bet-
ter  understood  HM  (P  =  0.012)  than  patients  who  were  afraid
of  receiving  a  phone  call.  High  comprehension  scores  were
associated  with  signiﬁcantly  less  fear  of  the  CM  than  low
comprehension  scores  (P  <  0.001).
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tMonitoring® (HM). All items are associated with the comprehension
verter deﬁbrillator.
cceptance  of  Home-Monitoring®
n  a  scale  from  —5  to  +5,  the  mean  acceptance  score  was
.8  ±  1.3.  HM  was  described  as  useful  by  366  of  369  patients
99%).  Patients  who  were  not  contacted  by  the  HM  Service
entre  had  a  signiﬁcantly  higher  mean  comprehension  score
P  =  0.007)  than  patients  who  needed  technical  support  to
eset  the  CM.  Should  HM  not  be  reimbursed  by  a  third  party,
atients  willing  to  absorb  the  cost  of  HM  had  signiﬁcantly
igher  comprehension  scores  (P  =  0.022)  than  patients  who
ere  unwilling  to  pay  (Fig.  2B).  Comprehension  of  HM  was
ositively  associated  with  its  acceptance  (P  <  0.001).  A  wish
o  continue  remote  monitoring  after  termination  of  the
tudy  was  expressed  by  98%  of  patients.
verall  satisfaction  with  Home-Monitoring®
y  univariate  analysis,  satisfaction  with  HM  was  associated
ith  anxiety,  comprehension  and  other  training  character-stics,  including  a  short  time  between  device  implantation
nd  CM  delivery,  comprehension  of  the  usefulness  of  the  sys-
em,  reading  of  the  user  manual  and  awareness  of  a  toll-free
elephone  number  for  technical  support.  By  multivariable
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Table  2  Baseline  characteristics  of  the  571  patients.
Characteristic
Age  (years)  63.9  ±  12.8
Left  ventricular  ejection  fraction  (%)  30.4  ±  10.9
Men  475  (83.2)
New  York  Heart  Association  functional
class
I  94  (16.5)
II  256  (45.2)
III  216  (38.2)
Missing  values  5  (0.1)
Prevention  indication
Primary  435  (76.2)
Secondary  136  (23.8)
Implanted  device
Single  chamber  172  (30.1)
Double  chamber  123  (21.5)
Triple  chamber  276  (48.3)
History  of  arrhythmias
Atrial  177  (31.0)
Ventricular  300  (52.5)
Cardiomyopathy  313  (54.6)
Ischaemic  173  (30.3)
Non-ischaemic  120  (21.0)
Others  20  (3.5)
Data are mean ± standard deviation or number (%).
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Table  4  Comparison  of  patients  who  completed  Ques-
tionnaire  1  before  versus  after  contact  with  the  Service
Centre.
Skills  score  Before  After  P
(n  =  10)  (n  =  7)
Overall  9.0  ±  5.2  13.0  ±  2.9  0.07
Medical  4.4  ±  3.3  4.3  ±  3.6  0.81
Technical 4.6  ±  3.9 8.7  ±  1.6  0.02
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ainear  regression  analysis,  the  anxiety  score  and  expeditious
elivery  of  the  CM  were  independently  associated  with  sat-
sfaction  with  HM  (Table  3).
®ata transmission rate by Home-Monitoring
he  mean  period  of  transmission  was  152  ±  47  days,  repre-
enting  80  ±  20%  of  the  overall  patients’  follow-up  period.
w
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Table  3  Univariate  and  multivariable  linear  regression  analys
Analysis
Univariate  
New  York  Heart  Association  functional
class
—0.10  (—0.29;  0.0
CM  delivery  0.49  (0.21;  0.77)  
Clarity  of  presentation  1.02  (0.43;  1.62)  
Attention  of  the  trainer  0.22  (—0.05;  0.49)
Familiarity  with  the  user  manual  —0.52  (—0.89;  —0.
Awareness  of  access  to  toll-free
telephone  number
—0.41 (—0.84;  0.0
Global  comprehension  score  0.04  (0.01;  0.06)  
Perception  score  0.09  (0.03;  0.15)  
Data are  (95% conﬁdence interval). Explanatory variables are listed
home monitoring at a level < 0.2 are listed in the table. CM: CardioMes
a Values entered into the multivariable model.Values are mean ± standard deviation.
he  period  of  transmission  was  >  80%  of  the  overall  follow-
p  period  in  61.4%  of  patients;  it  was  <  5%  of  the  follow-up
eriod  in  three  patients  (0.5%)  who  had  not  accepted  the  CM.
he  device  was  replaced  by  the  HM  Service  Centre  for  tech-
ical  issues  in  14  patients  (2.5%).  The  understanding  scores
nd  transmission  rates  were  not  associated.
By  protocol,  technical  support  was  offered  by  the  HM
ervice  Centre  to  30  patients  (7.5%)  for  non-transmission
ver  14  consecutive  days;  their  mean  transmission  rate  was
4.7  ±  20.7%,  compared  with  368  patients  (92.5%)  who  did
ot  require  technical  support  and  whose  mean  transmission
ate  was  85.6  ±  13.2%  (P  < 0.001).  In  these  30  patients,  the
ean  transmission  rate  increased  from  35.2  ±  27.4%  before,
o  72.4  ±  26.1%  after  they  were  contacted  by  technical  sup-
ort  to  ﬁx  the  transmission  issue.
Q-1  was  completed  by  10  patients  before  the  call  from
echnical  support  and  by  seven  patients  after  the  call;  it
as  not  completed  by  13  patients.  Once  the  technical  issue
as  resolved  by  technical  support,  the  mean  transmission
ates  were  similar  in  both  groups  of  patients.  However,  the
echnical  scores  of  the  seven  patients  who  completed  Q-1
fter  being  contacted  by  the  HM  Service  Centre  (8.7  ±  1.6)
ere  signiﬁcantly  higher  (P  =  0.02)  than  the  scores  of  the  10
atients  (4.6  ±  3.9)  who  completed  Q-1  before  being  con-
acted  by  the  Service  Centre  (Table  4).
es  of  satisfaction  with  home  monitoring.
P  Multivariable  P
9)  0.064a
0.001a 0.42  (0.12;  0.73)  0.027
0.003a
 0.157a
14)  0.013a
2)  0.05a
<  0.001a
<  0.001a 0.08  (0.01;  0.14)  0.027
 in Table 1. Variables statistically related to the satisfaction of
senger®.
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Shock delivery
A  total  of  122  shocks  were  delivered  in  42  patients  (7.4%)
during  the  study,  of  which  101  (83%)  were  classiﬁed  by
the  ICD  as  effective  and  21  (17%)  as  ineffective.  The
mean  number  of  shocks  was  0.03  ±  0.18  per  patient-month.
By  multivariable  logistic  regression  analysis,  patients  who
experienced  a  shock  were  more  likely  to  have  received  an
ICD  for  secondary  prevention,  were  more  often  called  by
their  physicians,  had  a  higher  acceptance  score  and  were
more  likely  to  fear  that  a  telephone  call  heralded  an  adverse
event,  than  patients  who  remained  shock  free  (Table  5).
Discussion
The  EDUCAT  study  is  the  ﬁrst  observational  study  to  show
that  a  high  overall  understanding  of  HM  is  closely  related  to
patient  age,  and  it  has  conﬁrmed  the  importance  of  training
in  their  acceptance  of  the  system.
Approximately  50%  of  ICD  recipients  have  depression  or
anxiety  attributed  to  the  presence  of  a  chronic  illness  and
their  awareness  of  being  at  risk  of  a  life-threatening  arrhyth-
mia  or  sudden  cardiac  death  [11].  The  awareness  of  being  at
risk  of  receiving  an  unexpected  ICD  shock  is  also  a  source  of
panic  disorder  or  anxiety  in  a  majority  of  patients  [12,13].
While  remote  monitoring  systems  have  become  the  pre-
ferred  means  of  ICD  follow-up  [2,3,5],  their  effects  on  mood
and  anxiety  are  not  well  known.  In  addition,  we  believe  that
patient  trust  in  the  system  is  a  key  to  the  success  of  this  new
technology.
Patient comprehension of Home-Monitoring®
After  their  postimplantation  training  by  the  hospital  staff
or  a  device  manufacturer’s  representative,  the  patients
completed  Q-1.  Only  seven  patients  completed  the  question-
naire  after  the  HM  Service  Centre  call  for  technical  support.
The  study  was,  therefore,  unbiased.  While  the  overall  level
of  comprehension  was  high,  the  test  scores  of  older  patients
were  lower.  Previous  studies  of  ICD  recipients  not  followed
remotely  found  that  the  more  informed  they  were,  the  more
accepting  they  were  of  their  disease  [14,15].  As  the  EDU-
CAT  registry  showed  a  high  overall  comprehension  score,  we
believe  that  all  patients  can  become  conversant  with  this
new  technology,  as  long  as  older  persons  are  trained  with
special  attention.
Effect of training conditions on
comprehension level
As  expected,  training  conditions  might  inﬂuence  level
of  comprehension.  We  found  that  merely  reading  the
informed  consent  form  or  being  familiar  with  the  toll-free
access  to  technical  support  helped  patients  to  understand
HM.  Detailed  explanations  from  the  device  manufacturer’s
representative  and  manipulation  of  the  device  during
the  training  period  were  also  effective.  These  observa-
tions  should,  perhaps,  prompt  caregivers  to  pay  more
attention  to  details  when  introducing  patients  to  remote
monitoring.
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ffect of comprehension level on patient
nxiety
 thorough  understanding  of  HM  was  associated  with  less
nxiety  regarding  the  physical  characteristics  of  the  CM
small  and  simple  versus  bulky  and  complicated).  We  found
igher  comprehension  scores  among  patients  who  paid  lit-
le  attention  to  the  CM  or  who  remained  calm  when  the
hone  was  ringing,  than  among  patients  who  regularly  veri-
ed  that  the  CM  was  functioning  or  feared  that  each  phone
all  heralded  an  ICD  complication.
ffect of comprehension level on patient
cceptance
e  found  that  the  higher  the  comprehension  of  HM
he  higher  the  acceptance  score.  We  also  found  that
pprehension  score  and  short  time  to  CM  delivery  after
CD  implantation  were  independent  positive  predictors
f  acceptance  score.  The  value  attributed  to  HM  by
atients  with  high  comprehension  scores,  and  their  will-
ngness  to  personally  absorb  the  cost  of  HM,  seemed  to
e  a  reliable  means  of  measuring  their  acceptance  of
he  CM.
ffect of comprehension level on data
ransmission rates
 minority  of  patients  had  to  be  called  for  failing  to  use
he  CM.  These  patients’  comprehension  scores  were  unre-
ated  to  transmission  rates  or  to  the  technical  issues  that
ccurred  during  the  ﬁrst  six  months  of  follow-up.  Not  surpris-
ngly,  we  found  that  the  telephone  support  offered  to  7.5%
f  patients  increased  their  technical  understanding  and,  on
verage,  doubled  their  transmission  rate.  Compared  with  a
ecent  study  testing  another  remote  system  [7],  the  need
or  assistance  to  obtain  reliable  transmissions  was  4-fold  to
-fold  less  frequent  in  this  study;  this  might  be  explained  by
he  simplicity  of  the  HM  system,  which  demands  no  direct
ntervention  on  the  part  of  the  patient.
hock delivery
n  objective  of  this  study  was  to  determine  whether  HM
ight  exacerbate  anxiety  and,  as  a  consequence,  increase
he  risk  of  arrhythmias  and  the  rate  of  shock  delivery.  Pre-
ious  reports  have  shown  that  decreasing  vagal  activity
nd  increasing  sympathetic  activity  associated  with  mental
epression  [16]  promotes  arrhythmic  events.  The  0.03  mean
umber  of  shocks  per  patient-month  in  EDUCAT  is  similar  to
ther  ICD  studies  with  HM  and  no  higher  than  comparable
CD  studies  without  HM  [2]. As  reported  earlier,  we  found
hat  patients  who  had  received  shocks  were  more  likely  to
ave  undergone  ICD  implants  for  a  secondary  prevention
ndication  [17].
The  42  patients  (7.4%)  who  received  ≥  1  shock  were  more
ikely  to  be  afraid  of  receiving  a  phone  call  from  their  care-
ivers,  although  they  had  a  higher  HM  acceptance  score  than
he  patients  who  had  received  no  shock.  We  found  no  asso-
iation  between  fear  of  HM  and  shock  frequency.
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Table  5  Univariate  and  multivariable  logistic  regression  analyses  of  shock  delivery.
All  patients  (n)  Shock  recipientsa Analysis
Univariateb P  Multivariablec P
Left  ventricular
ejection
fraction
357  21  (5.9)  1.03  (1.00;  1.05)  0.088d
Acceptance  score  357  21  (5.9)  1.58  (1.11;  2.25)  0.016d 2.3  (1.12;  4.74)  0.024
Sex  0.168d
Men  295  20  (6.8)  1
Women  62  1  (1.6)  0.484  (0.17;  1.39)
Implantation
indication
0.001d 0.034
Secondary  96  10  (10.4)  1  1
Primary  261  11  (4.2)  0.37  (0.20;  0.70)  0.21  (0.05;  0.89)
Left  ventricular
ejection
fraction
measured
0.138d
No  17  3  (17.6)  1
Yes  340  18  (5.3)  0.45  (0.15;  1.37)
Informed  consent
read
0.175d
No  102  5  (4.9)  1
Yes  255  16  (6.3)  1.96  (0.73;  5.28)
Fearful  that  a
phone  call
heralds
adverse  event
0.027d 0.006
Yes  29  5  (17.2)  1  1
No  328  16  (4.9)  0.28  (0.10;  0.81)  0.12  (0.03;  0.54)
Call  from
caregiver
< 0.001d 0.003
Yes  56  11  (19.6)  1  1
No  301  10  (3.3)  0.13  (0.05;  0.31)  0.15  (0.04;  0.53)
Willing  to  absorb
cost  of  HM
0.169d
No  176  7  (4.0)  1
Yes 181  14  (7.7)  1.86  (0.76;  4.55)
Variables statistically related to the shock delivery at a level < 0.2 are listed in the table. HM: home monitoring.
a Data are number (%).
b Data are unadjusted odds ratio (95% conﬁdence interval).
c Data are adjusted odds ratio (95% conﬁdence interval).
d Values entered into the multivariable model.
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iWe  believe  that  HM  may  have  played  a  reassuring  role  by
eminding  the  patients  that  their  caregivers  were  aware  of
heir  medical  status  after  each  shock.  The  phone  call  and  the
are  that  they  received  after  the  shock  may  have  provided
eassurance  that  they  were  being  effectively  supervised
emotely.
tudy limitationshile  several  home  monitoring  systems  are  available,
his  study  evaluated  only  the  Biotronik  remote  monitor-
ng  system  for  several  reasons.  We  chose  to  develop  the
roject  with  the  company  that  had  the  oldest  and  most
p
i
txtensive  home  monitoring  system.  Biotronik  has  a  user-
riendly  transmitter  without  pairing  process  and,  in  France,
 service  dedicated  to  technical  issues  encountered  by
atients.  Furthermore,  in  the  absence  of  reimbursement,
he  manufacturer  had  to  provide  the  equipment  at  the
eginning  of  the  study.
Another  limitation  pertains  to  the  application  of  the
esults,  obtained  in  ICD  recipients  whose  clinical  character-
stics  differ  from  those  of  typically  older  permanently-paced
atients,  in  whom  it  might  be  appropriate  to  perform  a  sim-
lar  study.
Finally,  the  patients  had  to  sign  an  informed  consent  form
o  participate  in  the  study;  this  could  have  induced  a  bias  in
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patient  selection.  However,  patients  had  to  sign  a  consent
form  for  HM,  whether  or  not  they  were  included  in  a  study
protocol.
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Appendix.
The  French  investigators  and  institutions  listed  below  partic-
ipated  in  the  EDUCAT  registry.  Principal  investigator:  Gabriel
Laurent,  MD,  CHU  Le  Bocage,  Dijon.  Co-investigators:
Walid  Amara,  MD,  CHI  Montfermeil,  Montfermeil;  Claude
Attia,  MD,  centre  chirurgical  Floréal,  Bagnolet;  Mohamed
Belhameche,  MD,  CH  de  Lagny  sur  Marne,  Lagny  sur  Marne;
Henri  Benkemoun,  MD,  clinique  Saint  Pierre,  Perpignan;
Olivier  Billon,  MD,  CHD  Vendée,  La  Roche  sur  Yon;  Olivier
Bizeau,  MD,  CHR  Orléans  La  Source,  Orléans;  Dominique
Bleinc,  MD,  CHP  Claude  Galien,  Quincy  sous  Sénart;  Aimé
Bonny,  MD,  hôpital  Sainte  Camille,  Bry  sur  Marne;  Michel
Boursier,  MD,  CHR  Bon  Secours,  Metz;  Florent  Briand,  MD,
CHU  Jean  Minjoz,  Besanc¸on;  Paul  Bru,  MD,  CH  de  La
Rochelle,  La  Rochelle;  Olivier  Cesari,  MD,  clinique  Saint
Gatien,  Tours;  Alain  Chapelet,  MD,  clinique  cardiologique
d’Aressy,  Pau;  Patrick  Chenevez,  MD,  clinique  Saint  Gatien,
Tours;  Isabelle  Cheradame,  MD,  CH  Jacques  Monod,  Le
Havre;  Philippe  Chevalier,  MD,  Hôpital  Cardiologique  Louis
Pradel,  Lyon;  Philippe  Couderc,  MD,  clinique  cardiologique
d’Aressy,  Pau;  Antoine  Da  Costa,  MD,  hôpital  universitaire
Nord  Saint  Étienne,  Saint  Étienne;  Nicolas  Delarche,  MD,
CH  Pau,  Pau;  Pierre  Fiorello,  MD,  centre  médico-chirurgical
Parly  II,  Le  Chesnay;  Benjamin  Gal,  MD,  hôpital  Saint-Joseph
Saint-Luc,  Lyon;  Stéphane  Garrigue,  MD,  clinique  Saint
Augustin,  Bordeaux;  Daniel  Gras,  MD,  Nouvelles  Cliniques
Nantaises,  Nantes;  Bruno  Grivet,  MD,  clinique  mutualiste
Eugène  André,  Lyon;  Yves  Guyomar,  MD,  CH  Saint  Philibert,
Lomme;  Franck  Halimi,  MD,  centre  médico-chirurgical517
arly  II,  Le  Chesnay;  Xavier  Harle,  MD,  CH  de  la  Côte
asque,  Bayonne;  Jean-Sylvain  Hermida,  MD,  CHU  Amiens
ud,  Amiens;  Hassiba  Hireche,  MD,  CH  de  la  Côte  Basque,
ayonne;  René-Gabriel  Huguet,  MD,  clinique  de  la  Reine
lanche,  Orléans;  Pierre  Khattar,  MD,  CH  de  Bretagne
ud,  Lorient;  Philippe  Lagrange,  MD,  clinique  Saint  Pierre,
erpignan;  Bernard  Lahitton,  MD,  hôpital  Général,  Dax;
illes  Lande,  MD,  CHU  Nantes,  Nantes;  Gilles  Lascault,  MD,
linique  cardiologique  du  Nord,  Saint-Denis;  Arnaud  Lazarus,
D,  Inparys,  Paris;  Christophe  Leclercq,  MD,  CHU  Pontchail-
ou,  Rennes;  Franc¸ois Legal,  MD,  CHU  La  Miletrie,  Poitiers;
hilippe  Mabo,  MD,  CHU  Pontchaillou,  Rennes;  Jacques
ansourati,  MD,  hôpital  de  la  Cavale  Blanche,  Brest;  Paul
illiez,  MD,  CHU  Caen,  Caen;  Cyrus  Moïni,  MD,  hôpital  privé
’Antony,  Antony;  Bertrand  Pierre,  MD,  CHRU  Trousseau,
ours;  Elena  Popescu,  MD,  CH  Jacques  Monod,  Le  Havre;
hilippe  Poret,  MD,  CMCO  pôle  santé  Sud,  Le  Mans;  Hervé
oty,  MD,  clinique  inﬁrmerie  Protestante,  Caluire  et  Cuire;
incent  Probst,  MD,  CHU  Nantes,  Nantes;  Sylvain  Reuter,
D,  clinique  Saint-Augustin,  Bordeaux;  Jean  Sacrez,  MD,
linique  Saint  Pierre,  Perpignan;  Aude  Solnon,  MD,  CHU
antes,  Nantes;  Franc¸ois-Xavier  Soto,  MD,  CH  Auxerre,
uxerre;  Guillaume  Théodore,  MD,  CHU  Pasteur,  Nice;
érôme  Thevenin,  MD,  centre  hospitalier  Privé  de  la  Loire,
aint  Étienne;  Olivier  Thomas,  MD,  clinique  Ambroise  Paré,
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